Literature DB >> 16751181

Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation.

Takeshi Miyatsuka1, Hideaki Kaneto, Toshihiko Shiraiwa, Taka-aki Matsuoka, Kaoru Yamamoto, Ken Kato, Yumiko Nakamura, Shizuo Akira, Kiyoshi Takeda, Yoshitaka Kajimoto, Yoshimitsu Yamasaki, Eric P Sandgren, Yoshiya Kawaguchi, Christopher V E Wright, Yoshio Fujitani.   

Abstract

The transcription factor pancreatic and duodenal homeobox factor 1 (PDX-1) is expressed in pancreatic progenitor cells. In exocrine pancreas, PDX-1 is down-regulated during late development, while re-up-regulation of PDX-1 has been reported in pancreatic cancer and pancreatitis. To determine whether sustained expression of PDX-1 could affect pancreas development, PDX-1 was constitutively expressed in all pancreatic lineages by transgenic approaches. The transgenic pancreas was markedly small with the replacement of acinar cells by duct-like structures, accompanied by activated Stat3. Genetic ablation of Stat3 in the transgenic pancreas profoundly suppressed the metaplastic phenotype. These results provide a mechanism of pancreatic metaplasia by which persistent PDX-1 expression cell-autonomously induces acinar-to-ductal transition through Stat3 activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751181      PMCID: PMC1475756          DOI: 10.1101/gad.1412806

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  34 in total

Review 1.  How cells change their phenotype.

Authors:  David Tosh; Jonathan M W Slack
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

2.  Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia.

Authors:  Anna L Means; Kevin C Ray; Amar B Singh; M Kay Washington; Robert H Whitehead; Raymond C Harris; Christopher V E Wright; Robert J Coffey; Steven D Leach
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

3.  Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis.

Authors:  Florian R Greten; Christoph K Weber; Tim F Greten; Günter Schneider; Martin Wagner; Guido Adler; Roland M Schmid
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

4.  Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis.

Authors:  T Miyatsuka; H Kaneto; Y Kajimoto; S Hirota; Y Arakawa; Y Fujitani; Y Umayahara; H Watada; Y Yamasaki; M A Magnuson; J Miyazaki; M Hori
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

5.  Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer.

Authors:  Masayuki Koizumi; Ryuichiro Doi; Eiji Toyoda; Toshihiko Masui; Sidhartha S Tulachan; Yoshiya Kawaguchi; Koji Fujimoto; George K Gittes; Masayuki Imamura
Journal:  Surgery       Date:  2003-08       Impact factor: 3.982

6.  Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer.

Authors:  Arne Scholz; Sandra Heinze; Katharina M Detjen; Michael Peters; Martina Welzel; Peter Hauff; Michael Schirner; Bertram Wiedenmann; Stefan Rosewicz
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

7.  PDX1 homeobox protein expression in pseudopyloric glands and gastric carcinomas.

Authors:  H Sakai; Y Eishi; X-L Li; Y Akiyama; S Miyake; T Takizawa; N Konishi; M Tatematsu; M Koike; Y Yuasa
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

8.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

Authors:  Sunil R Hingorani; Emanuel F Petricoin; Anirban Maitra; Vinodh Rajapakse; Catrina King; Michael A Jacobetz; Sally Ross; Thomas P Conrads; Timothy D Veenstra; Ben A Hitt; Yoshiya Kawaguchi; Don Johann; Lance A Liotta; Howard C Crawford; Mary E Putt; Tyler Jacks; Christopher V E Wright; Ralph H Hruban; Andrew M Lowy; David A Tuveson
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

9.  The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors.

Authors:  Yoshiya Kawaguchi; Bonnie Cooper; Maureen Gannon; Michael Ray; Raymond J MacDonald; Christopher V E Wright
Journal:  Nat Genet       Date:  2002-08-19       Impact factor: 38.330

10.  Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors.

Authors:  Guoqiang Gu; Jolanta Dubauskaite; Douglas A Melton
Journal:  Development       Date:  2002-05       Impact factor: 6.868

View more
  71 in total

1.  Negative regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5.

Authors:  Guisheng Zhou; Shi-He Liu; Kelly M Shahi; Hua Wang; Xueyan Duan; Xia Lin; Xin-Hua Feng; Min Li; William E Fisher; Francesco J Demayo; David Dawson; F Charles Brunicardi
Journal:  Mol Endocrinol       Date:  2012-06-05

2.  Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of beta-cells in Goto-Kakizaki rats.

Authors:  Zhen Li; Hong-Ya Zhang; Lu-Xian Lv; Dong-Fei Li; Jing-Xing Dai; Ou Sha; Wen-Qiang Li; Yu Bai; Lin Yuan
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

3.  Evidence for epithelial-mesenchymal transition in adult human pancreatic exocrine cells.

Authors:  Marjorie Fanjul; Valéry Gmyr; Coralie Sengenès; Ginette Ratovo; Marlène Dufresne; Bruno Lefebvre; Julie Kerr-Conte; Etienne Hollande
Journal:  J Histochem Cytochem       Date:  2010-06-07       Impact factor: 2.479

4.  Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.

Authors:  G Zhou; J Yu; A Wang; S-H Liu; J Sinnett-Smith; J Wu; R Sanchez; J Nemunaitis; C Ricordi; E Rozengurt; F C Brunicardi
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

5.  Pancreatic stellate cells and CX3CR1: occurrence in normal pancreas and acute and chronic pancreatitis and effect of their activation by a CX3CR1 agonist.

Authors:  Masahiko Uchida; Tetsuhide Ito; Taichi Nakamura; Masayuki Hijioka; Hisato Igarashi; Takamasa Oono; Masaki Kato; Kazuhiko Nakamura; Koichi Suzuki; Ryoichi Takayanagi; Robert T Jensen
Journal:  Pancreas       Date:  2014-07       Impact factor: 3.327

Review 6.  Defining the cancer master switch.

Authors:  Courtney J Balentine; David H Berger; Shi-He Liu; Changyi Chen; John Nemunaitis; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 7.  From tissue turnover to the cell of origin for pancreatic cancer.

Authors:  Bo Kong; Christoph W Michalski; Mert Erkan; Helmut Friess; Jörg Kleeff
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-12       Impact factor: 46.802

8.  Identification and manipulation of biliary metaplasia in pancreatic tumors.

Authors:  Kathleen E Delgiorno; Jason C Hall; Kenneth K Takeuchi; Fong Cheng Pan; Christopher J Halbrook; M Kay Washington; Kenneth P Olive; Jason R Spence; Bence Sipos; Christopher V E Wright; James M Wells; Howard C Crawford
Journal:  Gastroenterology       Date:  2013-08-30       Impact factor: 22.682

Review 9.  Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence.

Authors:  Veronique Giroux; Anil K Rustgi
Journal:  Nat Rev Cancer       Date:  2017-09-01       Impact factor: 60.716

10.  Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.

Authors:  Neus Martínez-Bosch; Maite G Fernández-Barrena; Mireia Moreno; Elena Ortiz-Zapater; Jessica Munné-Collado; Mar Iglesias; Sabine André; Hans-Joachim Gabius; Rosa F Hwang; Françoise Poirier; Carolina Navas; Carmen Guerra; Martin E Fernández-Zapico; Pilar Navarro
Journal:  Cancer Res       Date:  2014-05-08       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.